BlackBarn Capital Partners LP
Long book
$332.4M
Q1 2026
Positions
14
Top-10 weight
90%
concentration
Last quarter
+22.4%
SPY +14.8%
Turnover
33%
of book per quarter
Strategy in plain words
auto-generated from filingsBlackBarn Capital Partners LP is a concentrated fundamental stock-picker, running a $332.4M US long book across 14 positions.
The portfolio is extremely concentrated — the top 10 positions are almost the whole book. The portfolio is actively managed, with meaningful quarterly turnover. Current anchor positions: ROIVANT SCIENCES LTD, VEECO INSTRUMENTS INC, PRIVIA HEALTH GROUP INC, DIVERSIFIED HEALTHCARE TRUST, NEXTERA ENERGY INC.
Over the last 9 quarters its long book ran on average 3.2pp per quarter ahead of the S&P 500, beating the index in 6 of 9 quarters. We rate its filings highest-signal: new buys here are worth attention.
Implied long-book return vs S&P 500
methodology: positions priced quarterly, no shorts/options Fund long book S&P 500
Q1 2024
-3.4%
Q2 2024
+15.5%
Q3 2024
-5.1%
Q4 2024
-3.1%
Q1 2025
+2.6%
Q2 2025
+18.6%
Q3 2025
+16.7%
Q4 2025
+5.3%
Q1 2026
+22.4%
Sector allocation
Healthcare 49%
Industrials 15%
Technology 12%
Utilities 10%
Other 10%
Communications 3%
Services media 1%
Long book by quarter
What does BlackBarn Capital own?
Q1 2026 13F| Company | Sector | Shares | Value | % of book | Change |
|---|---|---|---|---|---|
| ROIV ROIVANT SCIENCES LTD | Healthcare | 2.3M | $63.3M | 19.0% | -25.9% |
| VECO VEECO INSTRUMENTS INC | Industrials | 1.0M | $33.9M | 10.2% | New |
| PRVA PRIVIA HEALTH GROUP INC | Healthcare | 1.6M | $32.6M | 9.8% | +21.9% |
| NEE NEXTERA ENERGY INC | Utilities | 335.0K | $31.1M | 9.4% | Held |
| MH MCGRAW HILL INC | Other | 2.1M | $28.6M | 8.6% | +49.2% |
| NIQ NIQ GLOBAL INTELLIGENCE PLC | Technology | 2.1M | $23.6M | 7.1% | +15.3% |
| AMRX AMNEAL PHARMACEUTICALS INC | Healthcare | 1.6M | $20.5M | 6.2% | +5.1% |
| VKTX VIKING THERAPEUTICS INC | Healthcare | 621.5K | $20.2M | 6.1% | +13.0% |
| NXPI NXP SEMICONDUCTORS NV | Technology | 60.0K | $11.8M | 3.6% | New |
| ABUS ARBUTUS BIOPHARMA CORP | Healthcare | 2.5M | $11.3M | 3.4% | +35.1% |
| GBTG GLOBAL BUSINESS TRAVEL GROUP | Industrials | 2.0M | $11.2M | 3.4% | New |
| CCOI COGENT COMMUNICATIONS HOLDIN | Communications | 500.0K | $9.4M | 2.8% | -23.1% |
| SEAT VIVID SEATS INC - CLASS A | Services media | 500.0K | $3.0M | 0.9% | New |
13F filing history
| Period | Form | Filed | Entries | Reported value | Flags | Source |
|---|---|---|---|---|---|---|
| Q1 2026 | 13F-HR | May 15, 2026 | 21 | $1.24B | canonical | SEC ↗ |
| Q4 2025 | 13F-HR | Feb 17, 2026 | 16 | $1.52B | canonical | SEC ↗ |
| Q3 2025 | 13F-HR | Nov 14, 2025 | 20 | $1.40B | canonical | SEC ↗ |
| Q2 2025 | 13F-HR | Aug 14, 2025 | 23 | $1.75B | canonical | SEC ↗ |
| Q1 2025 | 13F-HR | May 14, 2025 | 22 | $1.57B | canonical | SEC ↗ |
| Q4 2024 | 13F-HR | Feb 14, 2025 | 17 | $1.82B | canonical | SEC ↗ |
| Q3 2024 | 13F-HR | Nov 14, 2024 | 20 | $761.0M | canonical | SEC ↗ |
| Q2 2024 | 13F-HR | Aug 14, 2024 | 21 | $1.13B | canonical | SEC ↗ |
| Q1 2024 | 13F-HR | May 15, 2024 | 23 | $176.9M | canonical | SEC ↗ |
Similar funds
Sanders Capital, LLCGATES FOUNDATION TRUSTEAGLE CAPITAL MANAGEMENT LLCWoodbridge Co LtdAlecta Tjanstepension OmsesidigtMubadala Investment Co PJSCH&H International Investment, LLCNewlands Management Operations LLCINVESTOR ABIndependent Franchise Partners LLPPineStone Asset Management Inc.Pentwater Capital Management LP